Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Métodos Terapêuticos e Terapias MTCI
Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Br J Nutr ; 103(3): 314-8, 2010 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-19814835

RESUMO

Major surgery induces an immuno-inflammatory response accompanied by oxidative stress that may impair cellular function and delay recovery. The objective of the study was to investigate the effect of an enteral supplement, containing glutamine and antioxidants, on circulating levels of immuno-inflammatory markers after major gastrointestinal tract surgery. Patients (n 21) undergoing major gastrointestinal tract surgery were randomised in a single-centre, open-label study. The effects on circulating levels of immuno-inflammatory markers were determined on the day before surgery and on days 1, 3, 5 and 7 after surgery. Major gastrointestinal surgery increased IL-6, TNF receptor 55/60 (TNF-R55) and C-reactive protein (CRP). Surgery reduced human leucocyte antigen-DR (HLA-DR) expression on monocytes. CRP decrease was more pronounced in the first 7 d in the treatment group compared with the control group. In the treatment group, from the moment Module AOX was administered on day 1 after surgery, TNF receptor 75/80 (TNF-R75) level decreased until the third post-operative day and then stabilised, whereas in the control group the TNF-R75 level continued to increase. The results of the present pilot study suggest that enteral nutrition enriched with glutamine and antioxidants possibly moderates the immuno-inflammatory response (CRP, TNF-R75) after surgery.


Assuntos
Antioxidantes/uso terapêutico , Nutrição Enteral , Trato Gastrointestinal/cirurgia , Inflamação/prevenção & controle , Adolescente , Adulto , Idoso , Peptídeos Catiônicos Antimicrobianos/sangue , Antioxidantes/administração & dosagem , Proteínas Sanguíneas , Proteína C-Reativa/metabolismo , Antígenos HLA-DR/genética , Humanos , Interleucina-6/sangue , Interleucina-8/sangue , Contagem de Leucócitos , Pessoa de Meia-Idade , Monócitos/imunologia , Seleção de Pacientes , Complicações Pós-Operatórias/prevenção & controle , Estudos Prospectivos , Receptores de Interleucina-1/sangue , Adulto Jovem
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA